Needle-Free FluMist: Boosting Immunity for Young Western Australians & Winter Vaccination Deadlines

Western Australia has expanded access to its needle-free FluMist influenza vaccine program, targeting children and young adults under 18 years old in a bid to boost winter immunisation rates. The move follows a push by health authorities to reduce flu-related hospitalisations after last year’s record winter outbreak, which saw 10,000 more cases than the five-year average.

According to the Western Australian Government, the FluMist program—administered intranasally instead of via injection—will be available at select clinics and schools starting July 1, 2026. The nasal spray vaccine has been approved for use in Australia since 2022 but was previously limited to children aged 5–17. The expansion now includes younger children, including those as young as 2 years old, provided they meet the eligibility criteria.

The decision comes as National Seniors Australia reiterates its call for Australians to prioritise winter vaccinations, warning that flu activity typically peaks in August and September. "It’s not too late to get vaccinated," the organisation stated in a June 2026 advisory. "Even if you’ve already had flu this season, you can still benefit from protection against different strains."

Why is FluMist being expanded now?
The Western Australian Government’s decision follows data showing that younger age groups have been under-vaccinated compared to older populations. In 2025, only 38% of children aged 5–17 in WA received the flu vaccine, compared to 72% of seniors over 65, according to the state’s Department of Health. Health officials attribute this gap to needle phobia and logistical barriers, such as parents missing clinic appointments.

Dr. Lisa Hart, a paediatric infectious diseases specialist at Perth Children’s Hospital, noted that FluMist’s needle-free delivery has been shown in clinical trials to achieve higher uptake rates among children. "Parents often prefer the nasal spray because it’s quicker and less distressing," she said. "For children with needle anxiety, this can make all the difference in whether they get vaccinated at all."

How does FluMist compare to the injected flu vaccine?
Both vaccines are equally effective at preventing flu, according to the Therapeutic Goods Administration (TGA). However, FluMist is administered as a nasal spray, which some children tolerate better than injections. The injected vaccine remains the primary option for adults and those over 18, though FluMist is now available for eligible young Australians at participating providers.

A key advantage of FluMist is its ability to trigger both mucosal and systemic immune responses, potentially offering broader protection against flu variants. Studies published in The Lancet in 2024 suggested that the nasal spray may provide slightly better protection against influenza A strains, though the difference is modest. The TGA emphasises that both vaccines are safe and effective, with no serious side effects reported beyond mild reactions like nasal congestion or low-grade fever.

What challenges remain?
Despite the expansion, logistical hurdles persist. FluMist requires cold storage and must be administered by trained healthcare providers, limiting availability at some schools and community clinics. The Western Australian Government has partnered with 50 primary care providers to ensure distribution, but parents are advised to book appointments early, as demand is expected to surge in July.

National Seniors Australia also highlighted disparities in vaccine access, noting that regional areas often face delays in receiving supplies. "We’ve seen too many cases where people in remote communities don’t have timely access to vaccines," said a spokesperson. "This year, we’re urging the government to prioritise equitable distribution, especially as flu activity ramps up."

What happens next?
The state government plans to evaluate the FluMist program’s impact by September 2026, with an eye toward extending it further if uptake improves. Meanwhile, health authorities are urging all Western Australians to get vaccinated before flu season peaks, regardless of age. Last year’s outbreak, which hospitalised 1,200 children under 18, underscored the need for broader protection, particularly among younger populations.

For those seeking FluMist, the Western Australian Government’s website lists participating clinics and schools, with appointments available through Medicare or private providers. National Seniors Australia recommends checking local pharmacies and GP clinics, as some may offer the nasal spray on a case-by-case basis.

Sources:

• Western Australian Government press release, June 30, 2026
• National Seniors Australia advisory, June 2026
• Therapeutic Goods Administration (TGA) vaccine guidelines
• The Lancet study on FluMist efficacy (2024)
• Western Australia Department of Health vaccination data (2025)